Searched for
DAIICHI SANKYO INC
AstraZeneca, Gilead vie for edge in race to treat tough breast cancerNew data from Europe's biggest oncology meeting reveals a high-stakes race for patients with a tough breast cancer. Astra and Daiichi's Dat...- AstraZeneca, Daiichi Drug gets broad tumor approval in USEnhertu, a collaboration between AstraZeneca and Daiichi Sankyo, gains FDA approval for treating HER2-positive solid tumors spread througho...
- Japan stocks end higher on gains in drugmakers, tech stocksThe Nikkei 225 Index rose 0.33 per cent to 26,524.79, while the broader Topix rose 0.23 per cent to 1,765.21.
- Daiichi vs Singh Brothers: Delhi HC orders status quo on SRL Diagnostics trademark saleEarlier on June 24 Daiichi had sought for attachment sale of trademarks of Religare and Fortis too. The court had then issued notices to fo...
- Singapore SC dismisses Singh Bros' appeal against HC orderIn another setback for former Ranbaxy promoters Malvinder and Shivinder Singh, a Singapore Supreme Court on Thursday dismissed their appeal...
- Supreme Court to pronounce verdict on Singh brothersA bench of Chief Justice Deepak Gupta and Sanjiv Khanna will pronounce the judgment on Friday. The ruling is expected to impact the Fortis-...
- The CEO who capped a $37 billion recovery with AstraZeneca dealNakayama decided to reboot Daiichi Sankyo, pivoting toward the more lucrative business of cancer drugs.
- This drug may replace chemotherapy, redefine cancer careThese drugs will attack cancer cells in the body without damaging surrounding healthy ones.
- Lupin launches generic hypertension drug in US marketThe Mumbai-based company's product is the generic equivalent of Daiichi Sankyo Inc's Benicar tablets which is indicated for the treatment o...
- Lupin gets USFDA nod for cevimeline hydrochloride capsulesThe company's product is a generic version of Daiichi Sankyo Inc's Evoxac capsules, it added.
- Ajanta Pharma launches BP lowering tablets in USAjanta Pharma's Amlodipine + Olmesartan Medoxomil tablets are a generic version of Daiichi Sankyo Inc's Azor tablets
- Sun Pharma launches generic versions of Daiichi Sankyo's high blood pressure drugs in USThese brands together recorded US sales of approximately $2.5 billion between August 31, 2015 and August 31, 2016, Sun Pharma said, citing ...
- Ranbaxy launches generic version of Evoxac in US marketRanbaxy has launched generic cevimeline hydrochloride capsules, used in treating Sjogren's syndrome, in the US market.
- Glenmark settles patent row with Daiichi, GenzymeGlenmark Pharmaceuticals on Monday said it has settled a patent infringement litigation with Daiichi Sankyo and Genzyme.
- Glenmark settles patent infringement litigation with Daiichi, GenzymeThe company has received a licence from Daiichi Sankyo and Genzyme that will permit it to launch its generic Colesevelam Hydrochloride prod...
- Glenmark settles litigation with Daiichi Sankyo; stock upGlenmark Pharmaceuticals has reached at a settlement agreement with Daiichi Sankyo, Inc and Genzyme Corporation in regards with Glenmark’s ...
- Ranbaxy launches cholesterol drug in SAfricaRanbaxy Laboratories, India's largest drugmaker by sales, said on Tuesday its unit had launched atorvastatin, generic form of Pfizer Inc's ...
- Ranbaxy promoters may have to pay Rs 1k cr tax on Daiichi dealThe Securities and Exchange Board of India (Sebi) has rejected a plea from the promoters of Ranbaxy for a wavier of rules applicable to blo...
- Pfizer quashes Ranbaxy bid talks as 'rumours', shares soarWorld's biggest drugmaker Pfizer today termed as "rumours" talks about its interest in acquiring Indian pharma major Ranbaxy, even as share...
- Daiichi snaps up Ranbaxy for $4.6 bnA marauding Corporate India watched in stunned disbelief that the promoters of Ranbaxy were actually selling out.
Load More
